Vincenzo Cuomo Selected Research

ganstigmine

10/2007

Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: an in vivo study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vincenzo Cuomo Research Topics

Disease

7	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2002
7	Cognitive Dysfunction 01/2018 - 01/2002
3	Insulin Resistance 10/2007 - 03/2003
2	Psychotic Disorders (Schizoaffective Disorder) 10/2020 - 08/2010
2	Chronic Kidney Failure (Chronic Renal Failure) 02/2020 - 09/2004
2	Anhedonia 01/2014 - 01/2014
2	Memory Disorders (Memory Loss) 01/2014 - 04/2003
2	Shock 08/2007 - 01/2006
1	Inborn Genetic Diseases (Disease, Hereditary) 02/2020
1	Primary Hyperoxaluria (Oxaluria, Primary) 02/2020
1	Nephrolithiasis 02/2020
1	Nephrocalcinosis 02/2020
1	Renal Insufficiency (Renal Failure) 02/2019
1	Fabry Disease (Fabry's Disease) 02/2019
1	Myocardial Infarction 02/2019
1	Stroke (Strokes) 02/2019
1	Neuroinflammatory Diseases 01/2018
1	Dementia (Dementias) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Bone Resorption 01/2016
1	Amyloid Plaque 01/2014
1	Substance-Related Disorders (Drug Abuse) 01/2014
1	Major Depressive Disorder (Major Depressive Disorders) 02/2012
1	Schizophrenia (Dementia Praecox) 08/2010
1	Seizures (Absence Seizure) 08/2010
1	Hypoxia (Hypoxemia) 08/2009
1	Mood Disorders (Mood Disorder) 01/2009
1	Dyskinesias (Dyskinesia) 11/2007
1	Parkinson Disease (Parkinson's Disease) 11/2007
1	Alcoholism (Alcohol Abuse) 08/2007
1	Glioma (Gliomas) 09/2006
1	Type 2 Diabetes Mellitus (MODY) 10/2005
1	Hypertension (High Blood Pressure) 10/2005
1	Obesity 10/2005
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2004
1	Peritonitis 09/2004

Drug/Important Bio-Agent (IBA)

5	CannabinoidsIBA 03/2017 - 08/2007
4	Peptides (Polypeptides)IBA 01/2018 - 09/2006
3	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2014
3	Pharmaceutical PreparationsIBA 01/2017 - 01/2002
3	Insulin (Novolin)FDA Link 10/2007 - 03/2003
3	Glucose (Dextrose)FDA LinkGeneric 10/2007 - 03/2003
2	Ketamine FDA LinkGeneric 10/2020 - 08/2010
2	EnzymesIBA 02/2019 - 01/2018
2	Amyloid beta-PeptidesIBA 01/2015 - 09/2006
2	Sucrose (Saccharose)IBA 01/2014 - 01/2014
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2014 - 08/2010
2	Glutamic Acid (Glutamate)FDA Link 08/2010 - 04/2003
2	EndocannabinoidsIBA 11/2007 - 08/2007
1	lime (calcium oxide)FDA Link 02/2020
1	OxalatesIBA 02/2020
1	GlycosphingolipidsIBA 02/2019
1	alpha-Galactosidase (Beano)IBA 02/2019
1	eculizumab FDA Link 02/2019
1	Celecoxib (Celebrex)FDA Link 01/2018
1	AntioxidantsIBA 01/2018
1	ferulic acid (sodium ferulate)IBA 01/2018
1	biliverdin reductaseIBA 01/2018
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2018
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2018
1	Cathepsin KIBA 01/2016
1	Anabolic Androgenic SteroidsIBA 01/2014
1	Memantine (Namenda)FDA Link 01/2014
1	Nandrolone (Nortestosterone)IBA 01/2014
1	Stanozolol (Winstrol)FDA Link 02/2012
1	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2010
1	PlasticsIBA 08/2010
1	Nucleic AcidsIBA 08/2009
1	Transcription Factors (Transcription Factor)IBA 08/2009
1	8-Hydroxy-2'-DeoxyguanosineIBA 08/2009
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2009
1	Antidepressive Agents (Antidepressants)IBA 01/2009
1	Oxidopamine (6 Hydroxydopamine)IBA 11/2007
1	Levodopa (L Dopa)FDA LinkGeneric 11/2007
1	Fish OilsIBA 10/2007
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2007
1	Cholinergic Agents (Cholinergics)IBA 10/2007
1	ganstigmineIBA 10/2007
1	GABA-A Receptors (GABA(A) Receptor)IBA 09/2007
1	gamma-Aminobutyric Acid (GABA)IBA 09/2007
1	Dronabinol (THC)FDA LinkGeneric 09/2007
1	NeurosteroidsIBA 09/2007
1	RimonabantIBA 08/2007
1	Ethanol (Ethyl Alcohol)IBA 08/2007
1	tau Proteins (tau Protein)IBA 09/2006
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 09/2006
1	Proteins (Proteins, Gene)FDA Link 09/2006
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 09/2006
1	Cannabinoid Receptor AntagonistsIBA 01/2006
1	HDL CholesterolIBA 10/2005
1	Blood Glucose (Blood Sugar)IBA 10/2005
1	Genetic Markers (Genetic Marker)IBA 10/2005
1	Cytokine Receptor gp130IBA 09/2004
1	Interleukin-6 (Interleukin 6)IBA 09/2004
1	HemophanIBA 09/2004
1	Cannabinoid Receptor AgonistsIBA 04/2003

Therapy/Procedure

2	Therapeutics 01/2009 - 11/2007
1	Self Administration (Administration, Self) 08/2007
1	Drug Therapy (Chemotherapy) 08/2007
1	Peritoneal Dialysis 09/2004